Sabadell - SEMANAL MERCADOS: LOS RESULTADOS EMPRESARIALES, MENOS CATALIZADOR PARA LAS BOLSAS (ANÁLISIS BANCO SABADELL)

Report

Sabadell

Research Department

EUR 100.00 For Business Accounts Only

SEMANAL MERCADOS: LOS RESULTADOS EMPRESARIALES, MENOS CATALIZADOR PARA LAS BOLSAS (ANÁLISIS BANCO SABADELL)

Desde que terminó la campaña de Rdos. 3T’21 (15 de noviembre) el S&P500 ha perdido un -1,9%, el Euro STOXX un -2,9% y el Ibex 35 un -4,9%. Esta evolución responde más a las perspectivas sobre la política monetaria que a las expectativas sobre beneficios ncomo muestra la evolución sectorial del Euro STOXX donde destacan las mayores caídas del growth y/o los defensivos.

13/01/2022 1 ES

Provider

Sabadell

See profile

Analysts

Research Department

Other Reports from Sabadell

Oscar Rodriguez

Oscar Rodriguez

ACERINOX: FY2025 RESULTS AND T.P. INCREASE (ANÁLISIS BANCO SABADELL)

4Q'25 vs. 4Q'24 Results Sales: € 1.31 Bn (-1.3% vs. -24.1% BS(e) and -18.8% consensus); EBITDA: € 32 M (-78.7% vs. +116.6% BS(e) and +80.2% consensus); EBIT: € -23 M (116 M in 4Q'24 vs. 10 M BS(e) and 17 M consensus); Net Profit: € -47 M (€ 63 M in 4Q’24 vs. -15 M BS(e) and 17 M consensus); 2025 vs. 2024 Results Sales: € 5.78 Bn (+6.8% vs. +8.4% BS(e) and +6.2% consensus); EBITDA: € 354 M (-29.2% vs. -23.6% BS(e) and -20.0% consensus); EBIT: € 153 M (-56.0% vs. -46.6% BS(e) and -44.5% consensus); Net Profit: € -40 M (225 M in 2024 vs. -8 M BS(e) and 24 M consensus).

EUR 100.00

February 27, 2026 February 27, 2026 1 EN

Rafael Bonardell

Rafael Bonardell

VISCOFAN: 4Q’25 RESULTS (ANÁLISIS BANCO SABADELL)

4Q'25 vs. 4Q'24 Results Sales: € 315.12 M (+3.1% vs. +0.1% BS(e) and +2.2% consensus); EBITDA: € 71.75 M (-9.1% vs. +0.7% BS(e) and -2.3% consensus). FY2025 vs. FY2024 Results Sales: € 1.252 Bn (+4.0% vs. +3.2% BS(e) and +3.8% consensus); EBITDA: € 289.99 M (+1.6% vs. +4.3% BS(e) and +3.5% consensus).

EUR 100.00

February 27, 2026 February 27, 2026 1 ES

Andres Bolumburu

Andres Bolumburu

CELLNEX: FY2025 RESULTS (ANÁLISIS BANCO SABADELL)

4Q'25 vs. 4Q'24 Results Sales: € 1.058 Bn (+1.9% vs. -1.4% BS(e) and +1.0% consensus); EBITDA: € 881.0 M (+2.1% vs. +0.1% BS(e) and +1.0% consensus); FY2025 vs. FY2024 Results Sales: € 3.995 Bn (+1.4% vs. +0.5% BS(e) and +1.1% consensus); EBITDA: € 3.317 Bn (+2.1% vs. +1.5% BS(e) and +1.8% consensus); Net Profit: € -361.0 M (€ -28.0 M in FY2024);

EUR 100.00

February 27, 2026 February 27, 2026 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

SEMANAL MERCADOS: LOS RESULTADOS EMPRESARIALES, MENOS CATALIZADOR PARA LAS BOLSAS (ANÁLISIS BANCO SABADELL)

ACERINOX: FY2025 RESULTS AND T.P. INCREASE (ANÁLISIS BANCO SABADELL)

VISCOFAN: 4Q’25 RESULTS (ANÁLISIS BANCO SABADELL)

CELLNEX: FY2025 RESULTS (ANÁLISIS BANCO SABADELL)

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe